Abstract
Purpose
To analyze risk factors for parapharyngeal (PP) and retropharyngeal (RP) metastases in papillary thyroid cancer (PTC).
Methods
A matched case–control study was conducted, comprising 130 age- and sex-matched cases of PTC. Among these cases, 50 had PP/RP metastases, 50 had central and/or lateral neck lymph node metastases, and 30 showed no lymph node metastases. Preoperative thyroid function test, computed tomography images, and postoperative pathological findings were collected. Associations between cases were assessed using univariate conditional logistic regression analysis, followed by multivariate conditional logistic regression analysis, and backward stepwise selection to predict risk factors for PP/RP metastases.
Results
The study found that thyroglobulin was significantly associated with the development of PP/RP metastases [136.10(16.55–312.60) vs. 27.60(10.28–55.62) vs. 8.74(6.35–21.10) P < 0.001].
Conclusions
The study concludes that thyroglobulin is a significant risk factor for PP/RP metastases in PTC. This finding emphasizes the importance of monitoring thyroglobulin levels in PTC patients to identify those at risk of developing PP/RP metastases.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Megwalu UC, Moon PK (2022) Thyroid Cancer Incidence and Mortality Trends in the United States: 2000–2018. Thyroid Off J Am Thyroid Assoc 32(5):560–570
Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid Offi J Am Thyroid Assoc 16(2):109–142
Sandler ML, Xing MH, Levy JC et al (2021) Metastatic thyroid carcinoma to the parapharyngeal and retropharyngeal spaces: Systematic review with seven newly reported cases describing an uncommon presentation of a common disease. Head Neck 43(4):1331–1344
Batsakis JG, Sneige N (1989) Parapharyngeal and retropharyngeal space diseases. Ann Otol Rhinol Laryngol 98(4 Pt 1):320–321
Andrews GA, Kwon M, Clayman G, Edeiken B, Kupferman ME (2011) Technical refinement of ultrasound-guided transoral resection of parapharyngeal/retropharyngeal thyroid carcinoma metastases. Head Neck 33(2):166–170
Qiu ZL, Xu YH, Song HJ, Luo QY (2011) Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 131I-SPECT/CT. Head Neck 33(2):171–177
Amin MB, Greene FL, Edge SB et al (2017) The Eighth edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93–99
Harries V, McGill M, Tuttle RM et al (2020) Management of Retropharyngeal Lymph Node Metastases in Differentiated Thyroid Carcinoma. Thyroid Off J Am Thyroid Assoc 30(5):688–695
Moritani S (2016) Parapharyngeal Metastasis of Papillary Thyroid Carcinoma. World J Surg 40(2):350–355
Togashi T, Sugitani I, Toda K, Kawabata K, Takahashi S (2014) Surgical management of retropharyngeal nodes metastases from papillary thyroid carcinoma. World J Surg 38(11):2831–2837
McCormack KR, Sheline GE (1970) Retropharyngeal spread of carcinoma of the thyroid. Cancer 26(6):1366–1369
Ron E, Schneider ABJCe, prevention. Thyroid cancer. 2006:975–994.
Yin N, Sherman SI, Pak Y, Litofsky DR, Gianoukakis AG (2020) The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence. Thyroid Off J Am Thyroid Assoc 30(10):1490–1495
Evans C, Tennant S, Perros P (2015) Thyroglobulin in differentiated thyroid cancer. Clinica Chimica Acta Int J Clin Chem 444:310–317
Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid Off J Am Thyroid Assoc 19(11):1167–1214
Luna-Ortiz K, Navarrete-Alemán JE, Granados-García M, Herrera-Gómez A (2005) Primary parapharyngeal space tumors in a Mexican cancer center. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 132(4):587–591
Wang XL, Xu ZG, Wu YH, Liu SY, Yu Y (2012) Surgical management of parapharyngeal lymph node metastasis of thyroid carcinoma: a retrospective study of 25 patients. Chin Med J 125(20):3635–3639
Rouvier HJR (1932) Anatomie des lymphatiques de l’homme (anatomy of the human lymphatic system) 19(6):401–402
Desuter G, Lonneux M, Plouin-Gaudon I et al (2004) Parapharyngeal metastases from thyroid cancer. Eur J Surg Oncol J Europ Soc Surg Oncol Br Assoc Surg Oncol 30(1):80–84
Otsuki N, Nishikawa T, Iwae S, Saito M, Mohri M, Nibu K (2007) Retropharyngeal node metastasis from papillary thyroid carcinoma. Head Neck 29(5):508–511
Ducic Y, Oxford L, Pontius AT (2006) Transoral approach to the superomedial parapharyngeal space. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 134(3):466–470
Motta G, Testa D, Donadio A et al (2023) Transoral Approach to Parapharyngeal Space Tumours: Preliminary Reports from a Single-Centre Retrospective Analysis. Curr Oncol (Toronto, Ont) 30(4):3927–3939
Otsuki N, Morita N, Furukawa T, et al (2019) Functional and oncological outcomes after retropharyngeal node dissection for papillary thyroid carcinoma. European archives of oto-rhino-laryngology official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) affiliated with the German Society for Oto-Rhino-Laryngology Head and Neck Surgery 276(6):1809–1814
Xing M, Westra WH, Tufano RP et al (2005) BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90(12):6373–6379
Xing M, Alzahrani AS, Carson KA et al (2015) Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol Off J Am Soci Clin Oncol 33(1):42–50
Funding
This work was supported by the Natural Science Foundation of Zhejiang Province (No. LY20H160007 to Jinbiao Shang) and the National Natural Science Foundation of China (No. 82102749 to Qing Yu).
Author information
Authors and Affiliations
Contributions
DL: conception, design, acquisition of data, analysis, interpretation, manuscript writing, final approval; XN: design, acquisition of data, manuscript writing, final approval; QY: manuscript writing, final approval; JS: manuscript writing, final approval.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Ethical approval
This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Ethics Committee of Zhejiang Cancer Hospital (No. IRB-2020-64) approved this study.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, D., Nie, X., Yu, Q. et al. Risk factors for parapharyngeal and retropharyngeal metastases in papillary thyroid cancer: a matched case–control study. Eur Arch Otorhinolaryngol 281, 1531–1539 (2024). https://doi.org/10.1007/s00405-023-08404-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-08404-z